TIDMDCTA

Directa Plus PLC

03 February 2021

3 February 2021

Directa Plus plc

("Directa Plus" or the "Company")

EU grant received to further enhance Covid resistant face-masks

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that it has received a grant as part of the European Union's Horizon 2020 research and innovation programme.

The grant has a total value of EUR100,000, on a non-refundable basis, and covers a project which is expected to be concluded within the next 8 months.

As part of the Inno4Cov-19 Project, the grant will be used to assist Directa's research into using graphene technology to help prevent the spread of Covid-19. This will build on Directa's work undertaken during 2020 to develop the G+(R) face-mask and G+(R) filtering system.

The main technical targets of the projects are:

-- To undertake the extensive testing and improvement needed to qualify and market G+ enhanced surgical masks (compliant to European Standard EN 14683)

   --    The development of new biodegradable G+(R) enhanced filters

-- Development of a sanification process for the face-mask using household items such as an iron or a hairdryer

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "We are very proud of Directa's contributions so far to the fight against Covid-19.

"In conjunction with our research partners we have proven that graphene enhanced materials can hinder the spread of Covid more effectively than other fabrics.

"This grant will allow us to invest further and faster in improving the properties of our face-masks, allow us to supply them into clinical settings, and improve the environmental sustainability of their production."

-ends-

For further information please visit www.directa-plus.com or contact:

 
 Directa Plus plc                            +39 02 36714458 
 Giulio Cesareo, CEO 
 Marco Ferrari, CFO 
 
 Cenkos Securities plc (Nominated Adviser 
  and Joint Broker)                          +44 131 220 6939 
 Neil McDonald 
  Pete Lynch 
 
 N+1 Singer (Joint Broker)                   +44 20 7496 3069 
 Rick Thompson 
  Phil Davies 
 
 Tavistock (Financial PR and IR)             +44 20 7920 3150 
 Simon Hudson 
  Edward Lee

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber(R) product) and textiles (based on our G+(R) products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+(R) products. All our products are hypoallergenic, non-toxic and sustainably produced.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRADKBBNFBKDOBK

(END) Dow Jones Newswires

February 03, 2021 02:00 ET (07:00 GMT)

Directa Plus (LSE:DCTA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Directa Plus Charts.
Directa Plus (LSE:DCTA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Directa Plus Charts.